389 related articles for article (PubMed ID: 26984222)
1. Ground-Glass Opacity Lung Nodules in the Era of Lung Cancer CT Screening: Radiology, Pathology, and Clinical Management.
Pedersen JH; Saghir Z; Wille MM; Thomsen LH; Skov BG; Ashraf H
Oncology (Williston Park); 2016 Mar; 30(3):266-74. PubMed ID: 26984222
[TBL] [Abstract][Full Text] [Related]
2. How should we manage small focal pure ground-glass opacity nodules on high-resolution computed tomography? A single institute experience.
Yamaguchi M; Furuya A; Edagawa M; Taguchi K; Shimamatsu S; Toyokawa G; Toyozawa R; Nosaki K; Hirai F; Seto T; Takenoyama M; Ichinose Y
Surg Oncol; 2015 Sep; 24(3):258-63. PubMed ID: 26298200
[TBL] [Abstract][Full Text] [Related]
3. Clinical, pathological and thin-section CT features of persistent multiple ground-glass opacity nodules: comparison with solitary ground-glass opacity nodule.
Kim TJ; Goo JM; Lee KW; Park CM; Lee HJ
Lung Cancer; 2009 May; 64(2):171-8. PubMed ID: 18799230
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes of wedge resection for pulmonary ground-glass opacity nodules.
Cho JH; Choi YS; Kim J; Kim HK; Zo JI; Shim YM
Ann Thorac Surg; 2015 Jan; 99(1):218-22. PubMed ID: 25440277
[TBL] [Abstract][Full Text] [Related]
5. Management of Ground-Glass Opacities in the Lung Cancer Spectrum.
Zhang Y; Fu F; Chen H
Ann Thorac Surg; 2020 Dec; 110(6):1796-1804. PubMed ID: 32525031
[TBL] [Abstract][Full Text] [Related]
6. The diagnosis and treatment of lung cancer presented as ground-glass nodule.
Chen KN
Gen Thorac Cardiovasc Surg; 2020 Jul; 68(7):697-702. PubMed ID: 31823207
[TBL] [Abstract][Full Text] [Related]
7. Natural history of pure ground-glass opacity lung nodules detected by low-dose CT scan.
Chang B; Hwang JH; Choi YH; Chung MP; Kim H; Kwon OJ; Lee HY; Lee KS; Shim YM; Han J; Um SW
Chest; 2013 Jan; 143(1):172-178. PubMed ID: 22797081
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of one-dimensional mean computed tomography value of ground-glass opacity on high-resolution images for the possibility of future change.
Tamura M; Shimizu Y; Yamamoto T; Yoshikawa J; Hashizume Y
J Thorac Oncol; 2014 Apr; 9(4):469-72. PubMed ID: 24736068
[TBL] [Abstract][Full Text] [Related]
9. Management of multiple pure ground-glass opacity lesions in patients with bronchioloalveolar carcinoma.
Kim HK; Choi YS; Kim J; Shim YM; Lee KS; Kim K
J Thorac Oncol; 2010 Feb; 5(2):206-10. PubMed ID: 19901852
[TBL] [Abstract][Full Text] [Related]
10. Ground glass opacity resection extent assessment trial
Li H; Wang Y; Chen Y; Zhong C; Fang W
Front Oncol; 2023; 13():1052796. PubMed ID: 36741022
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and management of pulmonary nodules.
Krochmal R; Arias S; Yarmus L; Feller-Kopman D; Lee H
Expert Rev Respir Med; 2014 Dec; 8(6):677-91. PubMed ID: 25152306
[TBL] [Abstract][Full Text] [Related]
12. Present strategy of lung cancer screening and surgical management.
Ikeda N; Hayashi A; Miura Y; Okunaka T; Okuzawa K; Tsuboi M; Kato Y; Suga Y; Kato H
Ann Thorac Cardiovasc Surg; 2005 Dec; 11(6):363-6. PubMed ID: 16401983
[TBL] [Abstract][Full Text] [Related]
13. [Minute pulmonary meningothelial-like nodules （MPMNs） incidentally detected at surgical biopsy for ground-glass opacity（ GGO）].
Matsuoka T; Uematsu H; Iwakiri S; Itoi K
Kyobu Geka; 2012 Nov; 65(12):1063-6. PubMed ID: 23117359
[TBL] [Abstract][Full Text] [Related]
14. Approach to the ground-glass nodule.
Detterbeck FC; Homer RJ
Clin Chest Med; 2011 Dec; 32(4):799-810. PubMed ID: 22054887
[TBL] [Abstract][Full Text] [Related]
15. The diagnosis and management of multiple ground-glass nodules in the lung.
Li Q; Xiao T; Li J; Niu Y; Zhang G
Eur J Med Res; 2024 Jun; 29(1):305. PubMed ID: 38824558
[TBL] [Abstract][Full Text] [Related]
16. Survival of a surgical series of lung cancer patients with synchronous multiple ground-glass opacities, and the management of their residual lesions.
Shimada Y; Saji H; Otani K; Maehara S; Maeda J; Yoshida K; Kato Y; Hagiwara M; Kakihana M; Kajiwara N; Ohira T; Akata S; Ikeda N
Lung Cancer; 2015 May; 88(2):174-80. PubMed ID: 25758554
[TBL] [Abstract][Full Text] [Related]
17. [Early-stage lung cancer manifested as ground-glass opacity].
Jiang G; Xie D
Zhonghua Wai Ke Za Zhi; 2015 Oct; 53(10):790-3. PubMed ID: 26654312
[TBL] [Abstract][Full Text] [Related]
18. Management strategy of pulmonary nodule in 2013.
Lederlin M; Revel MP; Khalil A; Ferretti G; Milleron B; Laurent F
Diagn Interv Imaging; 2013 Nov; 94(11):1081-94. PubMed ID: 24034970
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive characterization of genomic and radiologic features reveals distinct driver patterns of RTK/RAS pathway in ground-glass opacity pulmonary nodules.
Yu F; Peng M; Bai J; Zhu X; Zhang B; Tang J; Liu W; Chen C; Wang X; Chen M; Tan S; Sun Y; Liang Q; Li J; Hu Y; Liao A; Hu H; He Y; Xiao X; Wang B; Xing G; Xu Y; Chen R; Xia X; Chen X
Int J Cancer; 2022 Dec; 151(11):2020-2030. PubMed ID: 36029220
[TBL] [Abstract][Full Text] [Related]
20. Invasiveness and surgical timing evaluation by clinical features of ground-glass opacity nodules in lung cancers.
Chen PH; Chang KM; Tseng WC; Chen CH; Chao JI
Thorac Cancer; 2019 Nov; 10(11):2133-2141. PubMed ID: 31571421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
